The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125778235 12577823 5 F 20160608 20160816 20160721 20160817 EXP DE-ROCHE-1782876 ROCHE 60.00 YR M Y 56.00000 KG 20160817 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125778235 12577823 1 PS Rituximab RITUXIMAB 1 Subcutaneous LAST DOSE PRIOR TO SAE ON 13/JUL/2016 U 103705 1400 MG SOLUTION FOR INJECTION Q3W
125778235 12577823 2 SS Rituximab RITUXIMAB 1 Subcutaneous U 103705 1400 MG SOLUTION FOR INJECTION
125778235 12577823 3 SS Pegfilgrastim PEGFILGRASTIM 1 Subcutaneous U 0 6 MG
125778235 12577823 4 SS Pegfilgrastim PEGFILGRASTIM 1 Subcutaneous U 0 6 MG
125778235 12577823 5 SS Pegfilgrastim PEGFILGRASTIM 1 Subcutaneous U 0 6 MG
125778235 12577823 6 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) U 0 1215 MG
125778235 12577823 7 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) LAST DOSE PRIOR TO SAE ON 13/JUL/2016 U 0 750 MG/M**2
125778235 12577823 8 SS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) LAST DOSE PRIOR TO SAE ON 13/JUL/2016 U 0 81 MG
125778235 12577823 9 SS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) U 0 50 MG/M**2
125778235 12577823 10 SS VINCRISTINE VINCRISTINE 1 Intravenous (not otherwise specified) LAST DOSE PRIOR TO SAE ON 13/JUL/2016 U 0 2 MG
125778235 12577823 11 SS VINCRISTINE VINCRISTINE 1 Intravenous (not otherwise specified) U 0 1 MG/M**2
125778235 12577823 12 SS PREDNISOLONE. PREDNISOLONE 1 Oral 0 100 MG QD
125778235 12577823 13 SS PREDNISOLONE. PREDNISOLONE 1 Oral 0
125778235 12577823 14 SS PREDNISOLONE. PREDNISOLONE 1 Oral 0 100 MG
125778235 12577823 15 SS COTRIM FORTE SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 0 860 MG
125778235 12577823 16 SS COTRIM FORTE SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 0 960 MG
125778235 12577823 17 SS ACIC ACYCLOVIR 1 Oral 0 800 MG
125778235 12577823 18 SS ACIC ACYCLOVIR 1 Oral 0 400 MG
125778235 12577823 19 C PROGRAF TACROLIMUSTACROLIMUS ANHYDROUS 1 Unknown 0 3.5 MG
125778235 12577823 20 C CYCLOSPORIN A CYCLOSPORINE 1 0
125778235 12577823 21 C CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Unknown 0 1 G
125778235 12577823 22 C AZATHIOPRINE. AZATHIOPRINE 1 0
125778235 12577823 23 C METOPROLOL. METOPROLOL 1 Unknown 0 150 MG
125778235 12577823 24 C RAMIPRIL. RAMIPRIL 1 0
125778235 12577823 25 C ASPIRIN. ASPIRIN 1 Unknown 0 100 MG
125778235 12577823 26 C OMEPRAZOL OMEPRAZOLE 1 Unknown 0 40 MG
125778235 12577823 27 C CHOLECALCIFEROL CHOLECALCIFEROL 1 Unknown 0 2 G
125778235 12577823 28 C ALLOPURINOL. ALLOPURINOL 1 Unknown 0 300 G
125778235 12577823 29 C ATORVASTATIN ATORVASTATIN 1 Unknown 0 20 MG
125778235 12577823 30 C CALCIUM ACETATE. CALCIUM ACETATE 1 Unknown 0 475 MG
125778235 12577823 31 C VIGANTOLETTEN CHOLECALCIFEROL 1 0
125778235 12577823 32 C TACROLIMUS. TACROLIMUS 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125778235 12577823 1 Post transplant lymphoproliferative disorder
125778235 12577823 3 Post transplant lymphoproliferative disorder
125778235 12577823 6 Post transplant lymphoproliferative disorder
125778235 12577823 8 Post transplant lymphoproliferative disorder
125778235 12577823 10 Post transplant lymphoproliferative disorder
125778235 12577823 12 Post transplant lymphoproliferative disorder
125778235 12577823 15 Post transplant lymphoproliferative disorder
125778235 12577823 17 Post transplant lymphoproliferative disorder

Outcome of event

Event ID CASEID OUTC COD
125778235 12577823 LT
125778235 12577823 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125778235 12577823 Arthritis
125778235 12577823 Cerebrovascular accident
125778235 12577823 Pyrexia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125778235 12577823 1 20160412 0
125778235 12577823 2 20160622 20160622 0
125778235 12577823 3 20160604 20160604 0
125778235 12577823 4 20160620 20160625 0
125778235 12577823 5 20160716 20160716 0
125778235 12577823 6 20160601 20160601 0
125778235 12577823 7 20160622 20160622 0
125778235 12577823 8 20160601 20160601 0
125778235 12577823 9 20160622 20160622 0
125778235 12577823 10 20160601 20160601 0
125778235 12577823 11 20160622 20160622 0
125778235 12577823 12 20160601 20160605 0
125778235 12577823 14 20160622 20160626 0
125778235 12577823 15 20160528 0
125778235 12577823 16 20160628 0
125778235 12577823 17 20160601 0
125778235 12577823 18 20160601 0
125778235 12577823 19 200403 0
125778235 12577823 21 200403 0